*There are minimal, if any, negative side effects
Caddy et al
Thus, we find that these two molecules have advanced in different areas: Melanotan-1 (SCENESSE, Clinuvel Pharmaceuticals Ltd) is being studied in phase 2 and phase 3 clinical trials as a photoprotective drug for protection against nonmelanoma skin cancer and in other photoinduced skin diseases, such as erythropoietic protoporphyria, solar dermatitis, and polymorphic light eruption
[DOI] [PMC free article] [PubMed] [Google Scholar] [18].Zhang X, Fei Y, Zhang M, Wei D, Li M, Ding W, Yang J, Reversal of osteoporotic changes of mineral composition in femurs of diabetic rats by insulin, Biol
In most studies, GIP remains ineffective and may even stimulate glucagon secretion, which naturally is counterproductive